Araştırma Makalesi

Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

Cilt: 47 Sayı: 1 31 Mart 2022
PDF İndir
TR EN

Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies

Abstract

Purpose: The study aimed at determining the success rate of sequential multi-dose methotrexate treatment in tubal ectopic pregnancy (EP) patients and the prognostic factors affecting the treatment success. Materials and Methods: Clinical, laboratory, and demographic data of 63 patients -hospitalized with the diagnosis of EP in our tertiary center between 2017-2020 and administered sequential multiple-dose methotrexate treatment protocol- were analyzed in this retrospective study. Results: Based on research findings, medical treatment was successful in 45 of the patients. It was found that 16 out of 18-patient, 88.8% of the patients in the failed group with methotrexate treatment, were operated on due to tubal rupture during follow-up. The mean of sonographic free fluid in Douglas of the successful group with methotrexate treatment was found to be 2.40±0.70 mm (Mean±SE), while it was 10.38±3.05 mm (Mean±SE) in the failed group at the first consultation. The initial β-hCG value of the successful group with methotrexate treatment was measured 3668.55±440.55 IU/L (Mean±SE), while it was 4929.72±752.65 IU/L (Mean±SE) in the failed group. Conclusion: The success rate of the sequential multiple dose methotrexate protocol was 71.4%. Both the initial serum β-hCG level and the amount of sonographic free fluid in the pouch of Douglas were found high in the failed group with medical treatment at the first consultation.

Keywords

Methotrexate , Ectopic Pregnancy , Tubal Rupture

Kaynakça

  1. Eriç HJ, Görkemli H, Özkaya EB, Işıkalan MM, Akıncı D, Kılıç F. Ektopik gebelik ve düşük tehdidi tanısında hemogram parametrelerinin değerlendirilmesi. Cukurova Med J. 2021;46:63-9.
  2. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J.. Ectopic Pregnancy. In Williams Obstetrics, 24th ed., New York, McGraw-Hill, 2014.
  3. Desroque D, Capmas P, Legendre G, Bouyer J, Fernandez H. Fertility after ectopic pregnancy. J Gynecol Obstet Biol Reprod (Paris). 2010;39:395-400.
  4. Spandana J, Tejaswini D, Bai GS. Clinical course of ectopic pregnancy: a tertiary centre experience. Int J Reprod Contracept Obstet Gynecol. 2017;6:2990-7.
  5. Baselice J, Yates M. Ectopic pregnancy. In The Johns Hopkins Manual of Gynecology and Obstetrics (Eds Hurt KJ, Guile MW, Bienstock JL, Fox HE, Wallach EE):340-9. New York, Lippincott Williams & Wilkins, 2012.
  6. van Mello NM, Mol F, Ankum WM, Mol BW, van der Veen F, Hajenius PJ. Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril. 2012;98:1066-73.
  7. Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ, Callaghan WM. Trends in ectopic pregnancy mortality in the United States: 1980-2007. Obstet Gynecol. 2011;117:837-43.
  8. Dhar H, Hamdi I, Rathi B. Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review. Oman Med J. 2011;26:94-8.
  9. Thacker J, Reardon R. Sonographic free fluid in patients with ectopic pregnancy. Ann Emerg Med. 2004;44:85.
  10. Sargin MA, Yassa M, Taymur BD, Çelik A, Aydin S, Orhan E et al. A clinical experience of ectopic pregnancies with initial free intraperitoneal fluid. J Clin Diagn Res. 2016;10:22-6.

Kaynak Göster

MLA
Çetin, Furkan, vd. “Analysis of multiple-dose methotrexate therapy in tubal ectopic pregnancies”. Cukurova Medical Journal, c. 47, sy 1, Mart 2022, ss. 397-04, doi:10.17826/cumj.1037172.